Abstract:A core-shell nanocarrier with triple layers, where each layer is sensitive to one specific physiological stimulus, has been fabricated for highly accurate cancer therapy. The nanocarrier consists of mesoporous silica nanoparticles (core structure for drug loading), fluorescein isothiocyanate-labeled hyaluronan (FITC-HA, first shell for imaging with enzymatic response), disulfide bond-embedded silica (SiO2, second layer with glutathione response), and switchable zwitterionic surface (third layer with pH response). The nanocarrier decorated with zwitterionic surface is able to offer long blood circulation time due to the weak nonspecific protein absorption. After these nanocarriers were gradually gathered around tumor cells through enhanced permeability and retention effect, the zwitterionic surface could switch to positive charge in low-pH environment, which was in favor of cellular uptake due to the strengthened positive nanocarrier-negative cellular membrane interaction. Once internalized into tumor cells, the high concentration of glutathione in cytoplasm could cleave disulfide bonds to remove the SiO2 shell and the HA layer would be exposed, which would be further degraded by hyaluronidase to trigger payload release. The fluorescent spectrum and images reveal that both glutathione and hyaluronidase are required for the release of preloaded drugs from these nanocarriers. By employing the multiple response, our nanocarriers could achieve effective antibiofouling ability while maintaining enhanced cellular internalization and targeted drug delivery, resulting in preferred cancer cell cytotoxicity, which is much higher than that of free doxorubicin. The in vitro data exhibited that our nanocarriers may provide an effective strategy for accurate cancer treatment.

A Ph-Responsive Dissociable Mesoporous Silica-Based Nanoplatform Enabling Efficient Dual-Drug Co-Delivery and Rapid Clearance for Cancer Therapy

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Super-pH-Sensitive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Effective Combination Cancer Therapy

Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles

A Ph-Responsive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Breast Cancer Therapy

Acid Susceptible Ultrathin Mesoporous Silica Coated On Layered Double Hydroxide Nanoplates For Ph Responsive Cancer Therapy

pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery

In Situ Monitoring of Intracellular Controlled Drug Release from Mesoporous Silica Nanoparticles Coated with Ph-Responsive Charge-Reversal Polymer

A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer

Ph-Responsive Size-Shrinkable Mesoporous Silica-Based Nanocarriers for Improving Tumor Penetration and Therapeutic Efficacy.

Multiple-Responsive Mesoporous Silica Nanoparticles for Highly Accurate Drugs Delivery to Tumor Cells

Supramolecular Modular Approach toward Conveniently Constructing and Multifunctioning a pH/Redox Dual-Responsive Drug Delivery Nanoplatform for Improved Cancer Chemotherapy

Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles

Multistage Ph-Responsive Mesoporous Silica Nanohybrids with Charge Reversal and Intracellular Release for Efficient Anticancer Drug Delivery

Cytochrome C Capped Mesoporous Silica Nanocarriers for Ph-Sensitive and Sustained Drug Release

Dual Responsive Mesoporous Silica Nanoparticles for Targeted Co-Delivery of Hydrophobic and Hydrophilic Anticancer Drugs to Tumor Cells.

A Ph-Responsive Mesoporous Silica Nanoparticles-Based Multi-Drug Delivery System for Overcoming Multi-Drug Resistance

A Drug-Self-gated and Tumor Microenvironment-Responsive Mesoporous Silica Vehicle: "Four-in-one" Versatile Nanomedicine for Targeted Multidrug-Resistant Cancer Therapy

Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery

pH-controllable drug carrier with SERS activity for targeting cancer cells.